News

IBM Pulls the Plug on Drug-Discovering Watson AI

IBM Pulls the Plug on Drug-Discovering Watson AI
Technology
On Thursday, STAT published  a story claiming that IBM is halting sales of Watson for Drug Discovery — a service that uses the company’s Watson AI to analyze connections between genes, drugs, and diseases on the hunt for useful new medications — citing as its source a person familiar with IBM’s internal decision-making.

“We are focusing our resources within Watson Health to double down on the adjacent field of clinical development where we see an even greater market need for our data and AI capabilities,” an IBM spokesperson told STAT — a sign that eight years after launching Watson Health, IBM still isn’t quite sure how AI should factor into the future of healthcare.

The STAT source cited a “lackluster financial performance” as IBM’s reason for no longer developing and selling Watson for Drug Discovery. That mirrors the “ lack of demand ” reasoning IBM gave for scaling back the part of Watson Health dedicated to helping hospitals manage certain contracts in June 2018.

It’s hard to imagine why the systems would be in high demand, though — several healthcare experts told IEEE Spectrum  earlier in April that IBM had “overpromised and underdelivered” with Watson Health.

“Merely proving that you have powerful technology is not sufficient,” healthcare data strategist Martin Kohn told the publication . “Prove to me that it will actually do something useful — that it will make my life better, and my patients’ lives better.”
Read more on futurism.com
News Topics :
Similar Articles :
Technology
After utterly crushing it on “Jeopardy ” IBM wanted to shift focus with its artificial intelligence division, Watson. The much hyped premise was that Watson would revolutionize healthcare, as a computer could feasibly...
Technology
Doctors spend years acquiring knowledge in various medical fields so that patients can feel confident that they are receiving the right diagnosis. The effectiveness of the patient’s treatment depends on...
Technology
Paul Tang was with his wife in the hospital just after her knee replacement surgery, a procedure performed on about 700, 000 people in the U.S. every year. The surgeon came...
Technology
IBM and MIT came together today to sign a 10 year, $240 million partnership agreement that establishes the MIT IBM Watson AI Lab at the prestigious Cambridge, MA academic institution. The lab...
Technology
Silicon Valley giants Apple and IBM will combine their machine learning expertise and solutions to make it easier for businesses to develop secure, AI powered solutions, the firms announced yesterday. Following...